AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Powers, JM Rosenblatt, DS Schmidt, RE Cross, AH Black, JT Moser, AB Moser, HW Morgan, DJ
Citation: Jm. Powers et al., Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency, ANN NEUROL, 49(3), 2001, pp. 396-400

Authors: Cross, AH Trotter, JL Lyons, JA
Citation: Ah. Cross et al., B cells and antibodies in CNS demyelinating disease, J NEUROIMM, 112(1-2), 2001, pp. 1-14

Authors: Cross, AH Landau, WM
Citation: Ah. Cross et Wm. Landau, In memoriam - John L. Trotter, MD (1943-2001), NEUROLOGY, 57(9), 2001, pp. 1534-1535

Authors: Cross, AH Ku, G
Citation: Ah. Cross et G. Ku, Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis, J NEUROIMM, 110(1-2), 2000, pp. 76-82

Authors: Cross, AH San, M Stern, MK Keeling, RM Salvemini, D Misko, TP
Citation: Ah. Cross et al., A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis, J NEUROIMM, 107(1), 2000, pp. 21-28

Authors: Segal, BM Cross, AH
Citation: Bm. Segal et Ah. Cross, Fas(t) track to apoptosis in MS - TNF receptors may suppress or potentiateCNS demyelination, NEUROLOGY, 55(7), 2000, pp. 906-907

Authors: Cross, AH
Citation: Ah. Cross, MS: The return of the B cell, NEUROLOGY, 54(6), 2000, pp. 1214-1215

Authors: Devere, TR Trotter, JL Cross, AH
Citation: Tr. Devere et al., Acute aphasia in multiple sclerosis, ARCH NEUROL, 57(8), 2000, pp. 1207-1209

Authors: Cross, AH San, M Keeling, RM Karr, RW
Citation: Ah. Cross et al., CTLA-4-Fc treatment of ongoing EAE improves recovery, but has no effect upon relapse rate. Implications for the mechanisms involved in disease perpetuation, J NEUROIMM, 96(2), 1999, pp. 144-147

Authors: Sabelko-Downes, KA Russell, JH Cross, AH
Citation: Ka. Sabelko-downes et al., Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease, J NEUROIMM, 100(1-2), 1999, pp. 42-52

Authors: Trotter, JL Keadle, TL Lauber, JM Dong, WL Cross, AH
Citation: Jl. Trotter et al., Increased frequency of recognition of delipidated versus intact CNS myelinin multiple sclerosis and control subjects, J NEUR SCI, 166(1), 1999, pp. 23-27

Authors: Benson, JM Stuckman, SS Cox, KL Wardrop, RM Gienapp, IE Cross, AH Trotter, JL Whitacre, CC
Citation: Jm. Benson et al., Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis, J IMMUNOL, 162(10), 1999, pp. 6247-6254

Authors: Sabelko-Downes, KA Cross, AH Russell, JH
Citation: Ka. Sabelko-downes et al., Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis, J EXP MED, 189(8), 1999, pp. 1195-1205

Authors: Lyons, JA San, M Happ, MP Cross, AH
Citation: Ja. Lyons et al., B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide, EUR J IMMUN, 29(11), 1999, pp. 3432-3439

Authors: Cross, AH Lyons, JA San, M Keeling, RM Ku, G Racke, MK
Citation: Ah. Cross et al., T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis, EUR J IMMUN, 29(10), 1999, pp. 3140-3147
Risultati: 1-15 |